MDM2 and chronic myelogenous leukemia, BCR-ABL1 positive: A number of recent studies have reported that small molecular inhibitors of MDM2 induce apoptosis in BCR/ABL expressing cells, including CML blast crisis cells regardless of the presence of the T315I mutation [18, 19].